58 min listen
Episode 171 -- D. James Surmeier PhD
ratings:
Length:
48 minutes
Released:
Apr 10, 2017
Format:
Podcast episode
Description
Monday, April 10, 2017
Jim Surmeier (Northwestern University) talks to us about integrating circuit, ion channel and bioenergetic vantage points to define quantitative, neuron-specific mechanisms of pathology in Parkinson’s disease. He guides the group through a discussion of how his hypothesis-driven approach is informing an exciting new clinical trial for slowing the progression of Parkinson’s disease.
Duration: 47 minutes
Discussants:(in alphabetical order)
Alfonso Apicella (Asst Prof, UTSA)
Salma Quraishi (Res Asst Prof, UTSA)
Asif Maroof (Asst Prof, UTSA)
Carlos Paladini (Professor, UTSA)
Todd Troyer (Assoc Prof, UTSA)
Matt Wanat (Asst Prof, UTSA)
Charles Wilson (Ewing Halsell Chair, UTSA)
acknowledgement: JM Tepper for original music.
Jim Surmeier (Northwestern University) talks to us about integrating circuit, ion channel and bioenergetic vantage points to define quantitative, neuron-specific mechanisms of pathology in Parkinson’s disease. He guides the group through a discussion of how his hypothesis-driven approach is informing an exciting new clinical trial for slowing the progression of Parkinson’s disease.
Duration: 47 minutes
Discussants:(in alphabetical order)
Alfonso Apicella (Asst Prof, UTSA)
Salma Quraishi (Res Asst Prof, UTSA)
Asif Maroof (Asst Prof, UTSA)
Carlos Paladini (Professor, UTSA)
Todd Troyer (Assoc Prof, UTSA)
Matt Wanat (Asst Prof, UTSA)
Charles Wilson (Ewing Halsell Chair, UTSA)
acknowledgement: JM Tepper for original music.
Released:
Apr 10, 2017
Format:
Podcast episode
Titles in the series (100)
Episode 1 -- James Tepper, PhD by Neuroscientists Talk Shop